HAProLink™ is a novel platform technology based on a proprietary novel Hyaluronic Acid (HA) chemistry that enables a unique, non destructive conjugation to proteins of choice. This technology allows better control of the final product compared to standard HA-protein conjugation methods, eliminating the formation of undesired side products.
HAProLink™ was first used for the development and production of a novel Viscosupplementation gel with resurfacing and regenerative potential for the treatment of Degenerative Joint Diseases, mainly Osteoarthritis (OA).
CellMate™ is another derivative of the HAProLink™ technology , and is a proprietary 3D cell delivery system based on conjugates of HA to ECM proteins.
The controlled release of growth factors and other small proteins/peptides is another important application of the HAProLink™ technology.